Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2

Towards the end of 2019, a novel coronavirus (CoV) named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), genetically similar to severe acute respiratory syndrome coronavirus (SARS-CoV), emerged in Wuhan, Hubei province of China, and has been responsible for coronavirus disease 2019 (CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jun-Gyu, Oladunni, Fatai S., Chiem, Kevin, Ye, Chengjin, Pipenbrink, Michael, Moran, Thomas, Walter, Mark R., Kobie, James, Martinez-Sobrido, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554492/
https://www.ncbi.nlm.nih.gov/pubmed/33068703
http://dx.doi.org/10.1016/j.jviromet.2020.113995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554492/
https://www.ncbi.nlm.nih.gov/pubmed/33068703
http://dx.doi.org/10.1016/j.jviromet.2020.113995

Ejemplares similares